ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ZCG-Backed Unimed Acquires MedSupply Florida, Expanding Cruise Industry Market Share

By: via Business Wire

Further Solidifies Position as a Leading Global Provider of Pharmaceutical and Medical Solutions to Maritime Industry

Universal Marine Medical Supply International (“Unimed” or the “Company”), the leading global provider of pharmaceutical and medical solutions to the maritime industry and a ZCG portfolio company, today announced the successful acquisition of MedSupply International FL, LLC (“MedSupply Florida”), a subsidiary of International SOS and a prominent supplier of medical provisions to the global cruise industry. Financial terms of the transaction were not disclosed.

Similar to Unimed, MedSupply Florida specializes in providing pharmaceuticals, medical equipment, and essential medical supplies. The strategic location of MedSupply Florida’s facilities at the Fort Lauderdale and Miami cruise ports aligns with Unimed’s long-term expansion objectives. Through this acquisition, Unimed is poised to enhance its services to cruise clients in the South Florida region.

“We are pleased to expand our presence in the booming cruise market while continuing to offer exceptional value and industry-leading essential, high-quality medical products and services,” said Alan Kessman, CEO of Unimed. “South Florida is a key port region for Unimed, and we are confident that our existing presence, strengthened by the acquisition of MedSupply Florida, will help us further enhance our longstanding customer relationships. Building on our recent merger with Marine Pharma in Singapore, this transaction represents another significant step in our value-creation strategy under ZCG ownership, positioning Unimed for continued organic growth and acquisition-driven expansion.”

“We are confident in the continued growth opportunities for Unimed to provide pharmaceutical and medical solutions, and meet the evolving demands of the maritime industry,” said James Zenni, Founder, President and Chief Executive Officer of ZCG. “This further expansion into global cruising aligns well with Unimed’s strategy, and we look forward to partnering with leadership and Unimed’s talented employees in this next phase of growth.”

About Unimed

Unimed is the industry leader in medical supply, equipment and oxygen distribution to global maritime industries, specializing in the delivery of integrated healthcare and safety supply chain logistical solutions to clients worldwide.

For more information, please visit https://universalmarinemedical.com/.

About ZCG

ZCG is a leading, privately held merchant bank comprised of private markets asset management, business consulting services, technology development and solutions.

For almost 30 years, ZCG Principals have invested tens of billions in capital and have industry leading track records in private equity and credit.

ZCG has approximately $7B of AUM in asset management and its investors are some of the largest and most sophisticated global institutional investors including pension funds, endowments, foundations, sovereign wealth funds, central banks, and insurance companies.

ZCG has a global team comprised of over 400 talented professionals. For more information, please visit www.zcg.com.

Contacts

Joele Frank, Wilkinson Brimmer Katcher

Tim Ragones / Kate Thompson / Erik Carlson

212-355-4449

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.